John Valliant - Net Worth and Insider Trading
John Valliant Net Worth
The estimated net worth of John Valliant is at least $7 Million dollars as of 2024-12-27. John Valliant is the CEO of Fusion Pharmaceuticals Inc and owns about 318,147 shares of Fusion Pharmaceuticals Inc (FUSN) stock worth over $7 Million. Details can be seen in John Valliant's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Valliant has not made any transactions after 2022-04-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Valliant
John Valliant Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Valliant owns 1 companies in total, including Fusion Pharmaceuticals Inc (FUSN) .
Click here to see the complete history of John Valliant’s form 4 insider trades.
Insider Ownership Summary of John Valliant
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2022-04-27 | director & Chief Executive Officer |
John Valliant Latest Holdings Summary
John Valliant currently owns a total of 1 stock. John Valliant owns 318,147 shares of Fusion Pharmaceuticals Inc (FUSN) as of April 27, 2022, with a value of $7 Million.
Latest Holdings of John Valliant
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2022-04-27 | 318,147 | 21.55 | 6,856,068 |
Holding Weightings of John Valliant
John Valliant Form 4 Trading Tracker
According to the SEC Form 4 filings, John Valliant has made a total of 13 transactions in Fusion Pharmaceuticals Inc (FUSN) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Fusion Pharmaceuticals Inc is the sale of 8,694 shares on April 27, 2022, which brought John Valliant around $52,512.
Insider Trading History of John Valliant
- 1
John Valliant Trading Performance
John Valliant Ownership Network
John Valliant Owned Company Details
What does Fusion Pharmaceuticals Inc do?
Who are the key executives at Fusion Pharmaceuticals Inc?
John Valliant is the director & Chief Executive Officer of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include Chief Medical Officer Dmitri Bobilev , Chief Scientific Officer Christopher P Leamon , and President and CBO Mohit Rawat .
Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fusion Pharmaceuticals Inc Insider Transactions
John Valliant Mailing Address
Above is the net worth, insider trading, and ownership report for John Valliant. You might contact John Valliant via mailing address: Fusion Pharmaceuticals Inc., 270 Longwood Road South, Hamilton A6 L8p 0a6.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
